An interventional study of Fenestration and Control in Incidence of Symptomatic Lymphocele After Kidney Transplantation and Prevalence of Perirenal Fluid Collections at One, Five and Ten Weeks, sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2010-09-22.
Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment
A single centre open randomised parallel-group study to evaluate whether prophylactic fenestration of the peritoneum at the time of renal transplantation prevents lymphocele formation.
Adult (>18 years old) recipients of renal transplants from deceased donors were eligible for inclusion. From March 2007 to May 2009 130 patients were included. The patients were randomized either to peroperative peritoneal fenestration, or to serve as controls. Block-randomization was conducted in groups of 10, drawn from envelopes containing five notes from each group. Patients who previously had undergone extensive abdominal surgery, or were included in other studies were excluded.
27 studies on the registry are indexed under Lymphocele; 3 are open to participants now.
This study's enrollment of 130 is above the median of 100 across 24 interventional studies indexed under Lymphocele.
Browse Lymphocele studies →Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Fenestration of the peritoneum according to the length of the transplanted kidney
Procedure: Fenestration
Standard kidney transplantation
Procedure: Control
Fenestration of the peritoneum according to the length of the transplanted kidney
Standard kidney transplantation
Incidence of symptomatic lymphoceles
Symptomatic lymphoceles treated by surgical intervetion or ultrasound guided drainage
Time frame: 1 - 3 years
Prevalence of fluid perirenal collections evaluated by ultrasound at 1, 5 and 10 weeks
Time frame: 1 -10 weeks
This study is completed, as verified in Mar 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital